In vitro studiet were performed using the rat phrenic nerve-hemidiaphragm preparation to investigate possible interactions between diisopropyl phenol and its solvent, cremophor, with three neuromuscular blocking drugs. Cumulative concentration curves were constructed for the neuromuscular blockers and linear regression analyses performed. Differences in the calculated effective concentration to produce a 50% decrease in twitch height (ECJO) and slope showed that diisopropyl phenol potentiated the action of suxamethonium, vecuronium (OrgNC45) and pancuronium. Cremophor potentiated the action of suxamethonium but antagonized the action of the non-depolarizing neuromuscular blockers. The possible mechanisms of action are discussed.
Diisopropyl phenol has been investigated as an induction agent for general anaesthesia and may be administered by either intermittent bolus or continuous infusion to maintain unconsciousness (Briggsetal., 1981; Major etal., 1981; Verniquetet al., 1981) . Since interactions have been reported between neuromuscular blocking drugs and other i.v. hypnotics (Booij and Crul, 1979; Krieg et al., 1980) , it seemed appropriate to assess the likelihood of any interaction between diisopropyl phenol and certain neuromuscular blocking drugs.
A study was undertaken to look for possible interactions between diisopropyl phenol (or cremophor, the solvent for diisopropyl phenol) and suxamethonium, vecuronium and pancuronium using the rat phrenic nerve-hemidiaphragm preparation, and to detect the site of action if interaction did occur.
MATERIALS AND METHODS
Isolated rat phrenic nerve-hemidiaphragm preparations (Biilbring, 1946) were obtained from Sprague-Dawley rats of 2 50-300 g body weight.
The preparations were placed in double-walled baths, perfused with mammalian Kreb's solution (sodium chloride 113.0; potassium chloride 4.7; calcium chloride 2.5; magnesium sulphate 1.2; sodium bicarbonate 25.0; sodium dihydrogen phosphate 2.5; and glucose 11.5mmollitre~'), aerated with 5% carbon dioxide in oxygen. Temperature (37°C) and pH (between 7.35 and 7.45 unit) were maintained constant. The techniques of stimulation and of recording the twitch response were those described by Foldes and colleagues (1969) , using supramaximal twitch stimuli of 0.2 ms at 0.1 Hz to the phrenic nerve. When the twitch heights had remained steady for at least 20 min, either 1% diisopropyl in 16% cremophor, 30iigml~l, or 16% cremophor alone were added to two-thirds of the baths. One-third of the baths had no drugs added and were used as controls. The concentration of cremophor when added alone was the same as that used as the solvent for diisopropyl and neither the diisopropyl phenol (plus cremophor) or the cremophor alone caused depression of twitch height when added to the bath. After another 30 min at the new steady state, cumulative concentration-response curves were determined using eight preparations for pancuronium, vecuronium (OrgNC45) and suxamethonium with each bath solution (blank, diisopropyl phenol, or cremophor alone), linear regression analyses were used to calculate the lines of best fit. At the end of each experiment, the preparation was washed with fresh Kreb's solution and the recovery observed.
Finally, in 10 preparations the neuromuscular junction was blocked with a large dose of pancuronium. Diisopropyl phenol was added to five of these diaphragm preparations to a concentration of l '. Every 20min the concentration of diisopropyl phenol was increased by 10/xgml" 1 while the muscle of the diaphragm was stimulated directly at 0.1 Hz. The other five preparations received no diisopropyl, were stimulated similarly, and served as controls. Cumulative concentration-response curves for diisopropyl phenol were constructed and fitted by linear regression analysis.
Comparisons of the ECM and slope of the dose-response curve of each neuromuscular blocker in the different bath solutions were made by analysis of variance and Student's ftest for unpaired data (Cooper, 1969) . The same method was used to compare the directly stimulated diaphragms with either diisopropyl or nothing added to the bath. .P<0.05 was considered significant.
RESULTS
The cumulative concentration-response curves for suxamethonium, vecuronium and pancuronium ( fig. 1) show that diisopropyl phenol shifted the curves of all three blocking drugs to the left. The greatest effect occurred with suxamethonium. Cremophor alone caused a shift in the curve for suxamethonium to the left and the curves for the nondepolarizing blockers to the right. Washing the preparation at the end of each experiment did not result in complete recovery of twitch height.
The mean concentrations ± the standard deviation required to produce a 50% twitch depression (EC50) and the slope of the calculated concentration-response curve are shown in table I. For suxamethonium, the EC50 and slope of each combination were different from every other combination (P< 0.01). For vecuronium, the EC50 of each combination was also different from every other combination (P<0.01). The slope of the combination of vecuronium + blank curve was similar to the slope of the vecuronium + cremophor curve, but the slope of the vecuronium + diisopropyl phenol curve was different from the other two combinations (P<0.01). The EQo and slope of the pancuronium + cremophor curve was similar to that produced by pancuronium + blank. However, they were both different (P<0.01) when comparisons were made between pancuronium -I-diisopropyl and the other two combinations.
At the greatest concentration of diisopropyl tested, 40 ngml" 1 , significant blockade of the directly stimulated diaphragms occurred when diisopropyl was added to the bath. A 70% depression of twitch height occurred, compared with a 17% depression of twitch height in the control preparations (mean values, P<0.01).
DISCUSSION
Diisopropyl phenol in the rat phrenic nerve-hemidiaphragm preparation potentiated the action of all three neuromuscular blocking drugs studied. Possible mechanisms of action would include a direct effect on the postjunctional membrane receptor, direct effect on the muscle, inhibition of acetylcholine release, and interference with cholinesterase activity. Since we could not obtain complete recovery upon washing the preparation, and because the response to direct stimulation of the muscle was inhibited by diisopropyl, it appears that the onset time of pancuronium administered with cremophor-containing anaesthetics (Gramstad, Lilleaasen and Minsaas, 1981) . However, the proposed mechanism of action of cremophor was interference with the intravascular binding sites for pancuronium, leaving more drug free for diffusion and as this could not happen in the in vitro experiments presented here, it cannot be the sole mechanism of action. We suggest further in vivo studies in both animals and man should be performed to determine if these findings have clinical implications for the possible concomitant use of diisopropyl phenol and neuromuscular blocking drugs.
this drug had an effect on the muscle itself which may be intracellular. Cremophor, however, appears to inhibit cholinesterase activity because it potentiated the effect of suxamethonium and inhibited the effect of the non-depolarizing blockers. We could speculate that, if diisopropyl was dissolved in a solvent which had not this interaction with nondepolarizing neuromuscular blockers, it would have had a greater potentiating effect on the nondepolarizing blockers in this in vitro preparation. The exact mechanism of action on the muscle itself is beyond the scope of this study. It is generally agreed that when drugs possess the same mechanism of action, the dose-response curves will have the same slope. The differences between the slopes in the suxamethonium groups are explicable because cremophor was demonstrated to have an inhibitory effect on cholinesterase activity while diisopropyl phenol had a direct effect on the muscle. The differences between the slopes in the vecuronium group may be caused partly by the fact that vecuronium is influenced to some extent by acetylcholinesterase (F. F. Foldes, personal communication) . Further experiments should clarify these points.
Cremophor is known to bind to proteins and biological membranes, and was shown to decrease 
INTERACCIONES DEL FENOL DMSOPROPIL aCI 35868) CON EL SUXAMETONIO, EL VECURONIO Y EL PANCURONIO IN VITRO
Se llevaron a cabo estudios m vitro con una preparaci6n de nervio frenico-hemidiafragma de rata con el objeto de averiguar les interacciones entre el fenol di-isopropil y su solvente, el cremofor, con tres substancias de bloqueo neuromuscular. Se establecieron las curvas de concentraci6n cumulativa de los ires bloqueadores neuromusculares y se Ilev6 a cabo el andlisis de la regreskSn linear. Las diferencias en la concentracidn efectiva calculada para producir un descenso del 50% de la altura de contracci6n (ECJO) y dc la inclinaddn indicaron que el fenol di-isopropil hacfa mis potente la acci6n del suxametonio, del vecuronio (OrgNC45) y del pancuronio. El cremofor hacfa mas potente la accidn del suxametonio pero antagonizaba la acci6n de los bloqueadores neuro-musculares no-depolarizante». Se discute de los posibles mecanismos de acci6n.
